COVID-19 Updates
From the Journals
Convalescent plasma cuts COVID-19 hospitalizations in half: Study
From the Journals
Bamlanivimab’s effects in COVID-19 depend on antibodies
Bamlanivimab was more effective in hospitalized COVID-19 patients without endogenous neutralizing antibodies.
From the Journals
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
The article in question investigated data integrity concerns at Pfizer vaccine clinical trial sites.
Commentary
COVID-19 and coping with superimposed traumas
Empathy burnout is also a real and important facet in the equation, said Dr. Cassondra Feldman.
Feature
Axilla swelling after COVID booster puts focus on mammogram timing
Experts and imaging center staff give recommendations regarding the timing of getting boosters and mammograms.
Latest News
Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
“I am hearing from colleagues from Washington state to Michigan to New York that this is the worst they have seen since the beginning of the...
Latest News
COVID cases spike as questions remain about Omicron’s threat
The Omicron variant has been detected in at least 39 states and 75 countries, according to CDC director Rochelle Walensky, MD.
From the Journals
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
The large-scale analysis suggests the risk is low with the adenovirus vaccine and pales in comparison with that following a positive SARS-CoV-2...
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
Conference Coverage
Telemedicine helps SCD patients survive COVID, but more need access
The second COVID-19 wave brought zero deaths and fewer complicated hospitalizations at the largest U.S. adult sickle cell disease center, but care...
News from the FDA/CDC
FDA updates risks, cautions for clotting-bleeding disorder on Janssen COVID-19 vaccine
“The known and potential benefits of the Janssen COVID-19 vaccine outweigh its known and potential risks in individuals 18 years of age and older...